DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional Reprogramming

By
Jamie Kang
-
0
107
Scientists explored the critical oncogenic pathways controlled by DNAJB1-PRKACA using patient-derived fibrolamellar carcinoma models, engineered systems, and patient samples.
[nan]
Abstract